Xiangrui Zhang

机构：Zhengzhou University

发表论文 6 篇 · 总被引 82 次 · h-index 4

代表论文

• Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy (2024 · Cell Communication and Signaling · 被引 27)
• Hemin blocks TIGIT/PVR interaction and induces ferroptosis to elicit synergistic effects of cancer immunotherapy (2024 · Science China Life Sciences · 被引 27)
• Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy (2023 · Biochemical Pharmacology · 被引 16)
• Dual targeting of TIGIT and PD-1 with a novel small molecule for cancer immunotherapy (2024 · Biochemical Pharmacology · 被引 11)
• CPNE7 promotes colorectal tumorigenesis by interacting with NONO to initiate ZFP42 transcription (2024 · Cell Death and Disease · 被引 1)
• Development of an Active Peptide Inhibitor to Block TIM-3/Gal-9 Interaction for Cancer Immunotherapy (2023 · SSRN Electronic Journal)